Current Considerations on Fibromyalgia Syndrome

JUAN ESTEBAN LOZANO-PLAZAS, Silvia Leonor Olivera Plaza, Lina María Sánchez Piedrahita, Nicolás Arturo Núñez Gómez

Texto completo:

PDF (English)

Resumen

Introducción: El Síndrome de Fibromialgia es una enfermedad idiopática que causa dolor musculoesquelético crónico permanente, provocando deterioro severo en la calidad de vida, discapacidad y alteraciones en la salud mental y física, así como pérdida de independencia y problemas cognitivos y psicosociales en quienes la padecen.

Objetivo: Describir el conocimiento actual sobre el Síndrome de Fibromialgia y ofrecer las perspectivas terapéuticas más frecuentes y efectivas, incluyendo el nuevo modelo de intervención que se podría sugerir con una estrategia sanológica.

Método: Se realizó una revisión narrativa de la literatura en las bases de datos PubMed, Scopus, Web of Science y Google Scholar. Se seleccionaron 128 artículos publicados entre 2017 y 2024 que cumplían criterios de relevancia, actualidad, rigor metodológico y alto impacto científico.

Resultados: Se presentan los hallazgos más relevantes sobre los mecanismos fisiopatológicos y epidemiológicos, principales comorbilidades, impacto biopsicosocial de la enfermedad, y las intervenciones terapéuticas tanto farmacológicas como no farmacológicas. Asimismo, se describen enfoques emergentes basados en la sanología, proponiendo nuevas perspectivas para el tratamiento integral de esta patología. Conclusiones: La comprensión actual de la fibromialgia exige enfoques terapéuticos

multidimensionales. La incorporación de modelos sanológicos puede representar una vía prometedora para mejorar el abordaje clínico y el bienestar integral de las personas afectadas.   

Palabras clave

Fibromyalgia; the impact of the disease; epidemiology.

Referencias

Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata J. Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos. Med Clin (Barc). 2017;149(10):441-8. doi: 10.1016/j.medcli.2017.06.008.

Wolfe F, Clauw D, Fitzcharles MA, Goldenberg R, Mease P, Russell A, Russell I, Winfield J, Yunus M. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-10. doi:10.1002/acr.20140.

Covarrubias-Gómez A, Carrillo-Torres O. Actualidades conceptuales sobre fibromialgia. Rev Mex Anestesiol. 2016;39(1):58-63. Available from: https://www.medigraphic.com/pdfs/rma/cma-2016/cma161g.pdf.

Velasco M. Dolor musculoesquelético: fibromialgia y dolor miofascial. Rev Méd Clin Las Condes. 2019;30(6):414-427. doi: 10.1016/j.rmclc.2019.10.002.

Mankır M, Ardıçoğlu Ö, Alkan B, Fidan F. Neuropathic pain in females with fibromyalgia syndrome: the role of obesity. Turk J Osteoporos. 2023;29:10-6. doi: 10.4274/tod.galenos.2022.62144.

Kılıçarslan A, Yurdakul FG, Bodur H. Diagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity. Turk J Phys Med Rehabil. 2018;64(2):133–139. doi: 10.5606/tftrd.2018.1618.

Mülkoğlu C, Ayhan FF. The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study. Mod Rheumatol. 2021;31(4):827-33. doi: 10.1080/14397595.2020.1823069.

De Tommaso M, Vecchio E, Nolano M. The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: A narrative review on neurophysiological and morphological evidence. Neurol Sci. 2022;43:1667-84. doi: 10.1007/s10072-021-05806-x.

Dumolard A, Lefaucheur JP, Hodaj E, Liateni Z, Payen JF, Hodaj H. Central sensitization and small-fiber neuropathy are associated in patients with fibromyalgia. Clin J Pain. 2023;39(1):8-14. doi: 10.1097/AJP.0000000000001085.

García D, Mendoza C. Fisiopatología de la fibromialgia. Reumatol Clin. 2020;16(3):191-194. doi:10.1016/j.reuma.2020.02.003.

Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B. Fibromyalgia. Nat Rev Dis Primers. 2015;1(1):1-16. doi:10.1038/nrdp.2015.22.

Amsterdam D, Buskila D. Etiology and triggers in the development of fibromyalgia. In: Ablin J, Shoenfeld Y, editors. Fibromyalgia Syndrome. Springer, Cham; 2021. doi: 10.1007/978-3-030-78638-0_3.

Szezerbaty S, Zicarelli C, de Lima L, Perrucini P, Fernandes K, Poli-Frederico R. COMT rs4680 single nucleotide polymorphism, ethnicity, and age are associated with fibromyalgia in women. Res Soc Dev. 2021;10(7). doi: 10.33448/rsd-v10i7.15225.

Muñóz-Gaytán DE, Guzmán-Silahua S, Orozco-Barocio G, Rodríguez-Ruiz JA, García-de la Torre I, Orozco-López G, et al. Consideraciones fisiopatogénicas en fibromialgia. Salud Jalisco. 2020;6(3):207-9. Available from: https://www.medigraphic.com/pdfs/saljalisco/sj-2019/sj193i.pdf.

Arnold L, Hudson J, Hess E, Ware A, Fritz D, Auchenbach M, Starck L, Keck Jr P. Family study of fibromyalgia. Arthritis Rheumatol. 2004;50(3):944-52. doi: 10.1002/art.20042.

Kaleycheva N, Cullen A, Evans R, Harris T, Nicholson T, Chalder T. The role of lifetime stressors in adult fibromyalgia: Systematic review and meta-analysis of case-control studies. Psychol Med. 2021;51(2):177-193. doi: 10.1017/S0033291720004547.

Carta M, Moro M, Pinna F, Testa G, Cacace E, Ruggiero V, Piras M, Romano F, Minerba L, Machado S, Freire R, Nardi A, Sancassiani F. The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life. Int J Soc Psychiatry. 2018;64(7):647-55. doi: 10.1177/0020764018795211.

Konak H, Sert H. Pain Levels in Female Patients with Fibromyalgia and Affecting Factors. Int J Caring Sci. 2018;11(3):1631-1637. Available from: http://internationaljournalofcaringsciences.org/docs/34_konak_riginal_11_3.pdf

Creed F. The risk factors for self-reported fibromyalgia with and without multiple somatic symptoms: The Lifelines cohort study. J Psychosom Res. 2022;155:110745. doi: 10.1016/j.jpsychores.2022.110745.

Guzmán-Silahua S, Muñoz-Gaytán D, Mendoza-Vázquez G, Orozco-Barocio G, Rodríguez-Ruiz J, de la Torre I, Orozco-López G, Nava-Zavala A. Fibromialgia. El Residente. 2018;13(2):62-67. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=81715.

Nijs J, George S, Clauw D, Fernández-de-las-Peñas C, Kosek E, Ickmans K, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5). doi: 10.1016/S2665-9913(21)00032-1.

Martínez-Lavín M. Fibromyalgia and small fiber neuropathy: the plot thickens! Clin Rheumatol. 2018;37(12):3167-71. doi: 10.1007/s10067-018-4300-2.

Martínez-Lavín M. Centralized nociplastic pain causing fibromyalgia: an emperor with no clothes? Clin Rheumatol. 2022;41(12):3915-7. doi: 10.1007/s10067-022-06407-5.

Theoharides TC, Tsilioni I, Bawazeer M. Mast cells, neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci. 2019;13:353. doi: 10.3389/fncel.2019.00353.

Kim DJ, Lim M, Kim J, Chung C. Structural and functional thalamocortical connectivity study in female fibromyalgia. Sci Rep. 2021;11(1):23323. doi: 10.1038/s41598-021-02616-1.

Feraco P, Nigro S, Passamonti L, Grecucci A, Caligiuri M, Gagliardo C, Bacci A. Neurochemical correlates of brain atrophy in fibromyalgia syndrome: A magnetic resonance spectroscopy and cortical thickness study. Brain Sci. 2020;10(6):395. doi:10.3390/brainsci10060395.

Murillo-García A, Leon-Llamas JL, Villafaina S, Gusi N. Fibromyalgia impact in the prefrontal cortex subfields: An assessment with MRI. Clin Neurol Neurosurg. 2022;219:107344. doi: 10.1016/j.clineuro.2022.107344.

Conti P, Gallenga CE, Caraffa A, Ronconi G, Kritas SK. Impact of mast cells in fibromyalgia and low-grade chronic inflammation: Can IL-37 play a role?. Dermatol Ther. 2020;33(1). doi: 10.1111/dth.13191.

Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37(11):1593-1601. doi: 10.1002/art.1780371106.

Bordoni B, Marelli F, Morabito B, Cavallaro F, Lintonbon D. Fascial preadipocytes: Another missing piece of the puzzle to understand fibromyalgia?. Open Access Rheumatol Res Rev. 2018;27-32. doi: 10.2147/OARRR.S155919.

Qureshi A, Jha S, Iskander J, Avanthika C, Jhaveri S, Patel V, Potini B, Azam AT. Diagnostic challenges and management of fibromyalgia. Cureus. 2021;13(10). doi: 10.7759/cureus.18692.

Coskun I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int. 2019;39(5):781-91. doi: 10.1007/s00296-019-04251-6.

Gyorfi M, Rupp A, Abd-Elsayed A. Fibromyalgia pathophysiology. Biomedicines. 2022;10(12):3070. doi:10.3390/biomedicines10123070.

Mezhov V, Guymer E, Littlejohn G. Central sensitivity and fibromyalgia. Intern Med J. 2021;51(12):1990-8. doi: 10.1111/imj.15430.

Úbeda-D’Ocasar E, Jiménez Díaz-Benito V, Gallego-Sendarrubias GM, Valera-Calero JA, Vicario-Merino Á, Hervás-Pérez JP. Pain and cortisol in patients with fibromyalgia: Systematic review and meta-analysis. Diagnostics. 2020;10(11):922. doi: 10.3390/diagnostics10110922.

Aksu E, Berk E, Sökmen A, Sökmen G, Celik E. Subclinical cardiac structural and electrical abnormalities in fibromyalgia syndrome. Turk J Med Sci. 2020;50(4):885-93. doi: 10.3906/hundimiento-1912-228.

Kobat MA. A frequent problem in systolic heart failure: Fibromyalgia. Cardiol Cardiovasc Med. 2021;5(4):395-403. doi: 10.26502/fccm.92920209.

Kulshreshtha P, Deepak KK, Yadav RK, Mukherjee D. Cardiac autonomic neuropathy in fibromyalgia: Revisited. J Back Musculoskelet Rehabil. 2022;35(1):111-117. doi: 10.3233/BMR-200209.

Assavarittirong C, Samborski W, Grygiel-Górniak B. Oxidative stress in fibromyalgia: From pathology to treatment. Oxid Med Cell Longev. 2022;2022:1582432. doi: 10.1155/2022/1582432.

González-Flores D, López-Pingarrón L, Castaño MY, Gómez MA, Rodríguez AB, García JJ, Garrido M. Melatonin as a coadjuvant in the treatment of patients with fibromyalgia. Biomedicines. 2023;11(7):1964. doi:10.3390/biomedicines11071964.

Leon-Llamas JL, Villafaina S, Murillo-Garcia A, Domínguez PR, Gusi N. Relationship between pineal gland, sleep and melatonin in fibromyalgia women: a magnetic resonance imaging study. Acta Neuropsychiatr. 2022;34(2):77-85. doi: 10.1017/neu.2021.35.

Pérez-Neri I, Sandoval H, Estêvão MD, Vasanthan L, Alarcon-Ruiz C, Ruszkowski J, Mathangasinghe Y, Ríos C, Pineda C. Central and peripheral mechanisms of pain in fibromyalgia: scoping review protocol. Rheumatology International. 2023;43(4):757-762. doi: 10.1007/s00296-023-05275-9.

Pinto AM, Luís M, Geenen R, Palavra F, Lumley M, Ablin J, Amris K, Branco J, Buskila D, Castelhano J, Castelo-Branco M, Crofford L, Fitzcharles MA, Häuser W, Kosek E, Mease P, Reis T, Jacobs J, Castilho P, da Silva J. Neurophysiological and psychosocial mechanisms of fibromyalgia: A comprehensive review and call for an integrative model. Neuroscience & Biobehavioral Reviews. 2023. doi: 10.1016/j.neubiorev.2023.105235.

Krumina A, Chapenko S, Kenina V, Mihailova M, Logina I, Rasa S, Gintere S, Viksna L, Svirskis S, Murovska M. The role of HHV-6 and HHV-7 infections in the development of fibromyalgia. J NeuroVirol. 2019;25:194-207. doi: 10.1007/s13365-018-0703-8.

De Carvalho JF, Lerner A. Fibromyalgia associated with Chagas' disease treated with nutraceuticals. Clin Nutr ESPEN. 2021;42:212-4. doi: 10.1016/j.clnesp.2021.01.037.

Pessano M, Silva E, Marchesan S. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023;31(2):633-651. doi: 10.1007/s10787-023-01160-w.

Cohen SP, Wang EJ, Doshi TL, Vase L, Cawcutt KA, Tontisirin N. Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies. BMJ Med. 2022;1(1). doi: 10.1136/bmjmed-2021-000108.

Häuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53-62. doi:10.31887/DCNS.2018.20.1/whauser.

Kozanoğlu E, Kelle B, Alaylı G, Kuru Ö, Çubukçu S, Demir A, Karakoç M, Özçakır Ş, Altay Z, Aktaş İ, Özkan F, Ayhan F, Çapkın E, Karkucak M, Kaya T, Uçar Ü, Erdal A, Taştekin N, Koyuncu E, Akıncı A. Frequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network. Arch Rheumatol. 2023;38(x). doi: 10.46497/ArchRheumatol.2023.9925.

Duffield S, Miller N, Zhao S, Goodson N. Comorbid fibromyalgia complicating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and spondyloarthritis: A systematic review and meta-analysis. Rheumatology. 2018;57(3). doi: 10.1093/rheumatology/key075.533.

López‐Escamez JA, Vela J, Frejo L. Immune‐Related Disorders Associated With Ménière's Disease: A Systematic Review and Meta‐analysis. Otolaryngol Head Neck Surg. 2023:1-10. doi: 10.1002/ohn.386.

Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, Letyagina Y, Kozlov E, Levshina A, Ivashkin V. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023;29(22):3400-3421. doi:10.3748/wjg.v29.i22.3400.

Minhas D, Marder W, Hassett AL, Zick S, Gordon C, Harlow S, et al. Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance program. Lupus. 2023. doi: 10.1177/09612033231186113.

Todor T, Fukudo S. Systematic review and meta-analysis of calculating degree of comorbidity of irritable bowel syndrome with migraine. BioPsychoSocial Med. 2023;17(1):22. doi: 10.1186/s13030-023-00275-4.

Ayouni I, Chebbi R, Hela Z, Dhidah M. Comorbidity between fibromyalgia and temporomandibular disorders: A systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128(1):33-42. doi: 10.1016/j.oooo.2019.02.023.

Bilge U, Sari YE, Balcioglu H, Yasar Bilge NS, Kasifoglu T, Kayhan M, Unluoglu I. Prevalence of comorbid diseases in patients with fibromyalgia: A retrospective cross-sectional study. JPMA J Pak Med Assoc. 2018;68(5):729-32. Available from: https://pubmed.ncbi.nlm.nih.gov/29885171/.

Løge-Hagen JS, Sæle A, Juhl C, Bech P, Stenager E, Mellentin A. Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis. J Affect Disord. 2019;245:1098-1105. doi: 10.1016/j.jad.2018.12.001.

Habibi M, Salehi P, Jafari F, Azami‐Aghdash S, Lumley M. The relationship of alexithymia to pain and other symptoms in fibromyalgia: A systematic review and meta‐analysis. Eur J Pain. 2023;27(3):321-337. doi:10.1002/ejp.2064.

Gill H, Perez C, Gill B, El-Halabi S, Lee Y, Lipsitz O, Park C, Mansur R, Rodrigues N, McIntyre R, Rosenblat J. The prevalence of suicidal behaviour in fibromyalgia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110078. doi:10.1016/j.pnpbp.2020.110078.

Adawi M, Chen W, Bragazzi NL, Watad A, McGonagle D, Yavne Y, Kidron A, Hodadov H, Amital D, Amital H. Suicidal behavior in fibromyalgia patients: Rates and determinants of suicide ideation, risk, suicide, and suicidal attempts-A systematic review of the literature and meta-analysis of over 390,000 fibromyalgia patients. Front Psychiatry. 2021;12:629417. doi: 10.3389/fpsyt.2021.629417.

Levine D, Horesh D. Suicidality in fibromyalgia: a systematic review of the literature. Front Psychiatry. 2020;11:535368. doi: 10.3389/fpsyt.2020.535368.

Galvez-Sánchez CM, Duschek S, Reyes Del Paso GA. Psychological impact of fibromyalgia: Current perspectives. Psychol Res Behav Manag. 2019;12:117-127. doi:10.2147/PRBM.S178240.

Izuno S, Yoshihara K, Hosoi M, Eto S, Hirabayashi N, Todani T, Gondo M, Hayaki C, Anno K, Hiwatashi A, Sudo N. Psychological characteristics associated with the brain volume of patients with fibromyalgia. BioPsychoSocial Med. 2023;17(1):36. doi: 10.1186/s13030-023-00293-2.

Galvez-Sánchez CM, Reyes del Paso GA, Duschek S. Cognitive impairments in fibromyalgia syndrome: Associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem. Front Psychol. 2018;9:377. doi:10.3389/fpsyg.2018.00377.

Gelonch O, Garolera M, Valls J, Rosselló L, Pifarré J. Cognitive complaints in women with fibromyalgia: Are they due to depression or to objective cognitive dysfunction? J Clin Exp Neuropsychol. 2017;39(10):1013-1025. doi:10.1080/13803395.2017.1301391.

Montoro C, Reyes G, Duschek S. Alexithymia in fibromyalgia syndrome. Pers Individ Dif. 2016;102:170-9. doi: 10.1016/j.paid.2016.06.072.

Moscati A, Faucon AB, Arnaiz-Yépez C, Lönn SL, Sundquist J, Sundquist K, et al. Life is pain: Fibromyalgia as a nexus of multiple liability distributions. Am J Med Genet B Neuropsychiatr Genet. 2023:1-12. doi: 10.1002/ajmg.b.32949.

Treister-Goltzman Y, Peleg R. Fibromyalgia and mortality: A systematic review and meta-analysis. RMD Open. 2023;9(3). doi: 10.1136/rmdopen-2023-003005.

Wolfe F, Ablin J, Baker J, Diab R, Guymer E, Littlejohn G, Michaud K, Rasker J, Walitt B, Häuser W. All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia. Semin Arthritis Rheum. 2020;50(6):1457-64. doi:10.1016/j.semarthrit.2020.02.005.

Marques A, de Sousa A, Berssaneti A, Matsutani L, King S. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol. 2017;57(4):356-63. doi: 10.1016/j.rbre.2017.01.005.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-28. doi: 10.1136/annrheumdis-2016-209724.

Creed F. A review of the incidence and risk factors for fibromyalgia and chronic widespread pain in population-based studies. Pain. 2020;16(6):1169-76. doi: 10.1097/j.pain.0000000000001819.

Wolfe F, Walitt B, Perrot S, Rasker J, Häuser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One. 2018;13(9). doi:10.1371/journal.pone.0203755.

Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37:1527-1539. doi:10.1007/s00296-017-3725-2.

Yunus D, Gamze A, Sevgi C, Yeliz Z, Ayhan B, Ilker I, Omer K. Prevalence of juvenile fibromyalgia syndrome in an urban population of Turkish adolescents: impact on depressive symptoms, quality of life and school performance. Chin Med J (Engl). 2013;126(19):3705-11. doi:10.3760/cma.j.issn.0366-6999.20130185.

Coles M, Weissmann R, Uziel Y. Juvenile primary fibromyalgia syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis. Pediatr Rheumatol. 2021;19(22). doi: 10.1186/s12969-021-00493-6.

Weiss J, Schikler K, Boneparth A, Connelly M. Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Pediatr Rheumatol. 2019;17(51). doi:10.1186/s12969-019-0356-z.

Vittori A, Cascella M, Leonardi M, Monaco F, Nocerino D, Cuomo A, Ottaiano A, Perri F, Mascilini I, Francia E, Petrucci E, Marinangeli F, Picardo S. VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS). Children (Basel). 2022;9(5):637. doi:10.3390/children9050637.

Coles M, Uziel Y. Juvenile primary fibromyalgia syndrome: A review—treatment and prognosis. Pediatr Rheumatol. 2021;19(74). doi: 10.1186/s12969-021-00529-x.

Durán J, Tejos-Bravo M, Cid V, Ferreccio C, Calvo M. Chronic pain in Chile: First prevalence report of noncancer chronic pain, fibromyalgia, and neuropathic pain and its associated factors. Pain. 2023;164(8):1852-9. doi: 10.1097/j.pain.0000000000002886.

Goren A, Gross H, Fujii R, Pandey A, Mould-Quevedo J. Prevalência da percepção e do tratamento da dor e de seus resultados de saúde em diferentes condições do Brasil. Rev Dor. 2012;13(4):308-319. doi:10.1590/S1806-00132012000400002.

Vega-Hinojosa O, Cardiel M, Ochoa-Miranda P. Prevalence of musculoskeletal manifestations and related disabilities in a Peruvian urban population living at high altitude. COPCORD study. Stage I. Reumatol Clin (Engl Ed). 2018;14(5):278-284. doi: 10.1016/j.reumae.2017.01.013.

Pelaez-Ballestas I, Sanin L, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R, Garza-Elizondo M, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol. 2011;86:3-8. doi: 10.3899/jrheum.100951.

Granados Y, Cedeno L, Rosillo C, Berbin S, Azocar M, Molina M, Lara O, Sanchez G, Peláez-Ballestas I. Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: A COPCORD study. Clin Rheumatol. 2015;34:871-7. doi:10.1007/s10067-014-2689-9.

Londoño J, Peláez-Ballestas I, Cuervo F, Angarita I, Giraldo R, Rueda J, Ballesteros J, Baquero R, Forero E, Cardiel M, Saldarriaga E, Vásquez A, Arias S, Valero L, González C, Ramírez J, Toro C, Santos A. Prevalencia de la enfermedad reumática en Colombia, según estrategia COPCORD-Asociación Colombiana de Reumatología. Estudio de prevalencia de enfermedad reumática en población colombiana mayor de 18 años. Rev Colomb Reumatol. 2018;25(4):245-256. doi: 10.1016/j.rcreu.2018.08.003.

Vincent A, Lahr B, Wolfe F, Clauw D, Whipple M, Oh T, Barton D, Sauver J. Prevalence of fibromyalgia: a population‐based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786-92. doi:10.1002/acr.21896.

Jones G, Beasley M, Atzeni F, Fluss E, Sarzi-Puttini P, Macfarlane G. The prevalence of fibromyalgia in the general population-a comparison of the ACR 1990, 2010 and modified 2010 classification criteria. Arthritis Rheumatol. 2013;65(S10). doi: 10.1002/art.38216.

Branco J, Bannwarth B, Failde I, Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubere J, Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: A survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448-53. doi: 10.1016/j.semarthrit.2008.12.003.

Zhang Y, Liang D, Jiang R, Ji X, Wang Y, Zhu J, Zhang J, Huang F. Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample. Clin Rheumatol. 2018;37:527-37. doi:10.1007/s10067-017-3872-6.

Mazo J, Estrada M. Implications of chronic pain on the quality of life of women with fibromyalgia. Psicologia em Estudo. 2018;23. doi: 10.4025/psicolestud.v23.e38447.

Fernandez-Feijoo F, Samartin-Veiga N, Carrillo-de-la-Peña MT. Quality of life in patients with fibromyalgia: Contributions of disease symptoms, lifestyle and multi-medication. Front Psychol. 2022;13:924405. doi:10.3389/fpsyg.2022.924405.

Choy EH. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 2015;11(9):513-20. doi: 10.1038/nrrheum.2015.56.

Cöster L, Kendall S, Gerdle B, Henriksson C, Henriksson K, Bengtsson A. Chronic widespread musculoskeletal pain – A comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain. 2012;12:600-10. doi: 10.1016/j.ejpain.2007.10.001.

Mukhida K, Carroll W, Arseneault R. Does work have to be so painful? A review of the literature examining the effects of fibromyalgia on the working experience from the patient perspective. Can J Pain. 2020;4(1):268-86. doi: 10.1080/24740527.2020.1820858.

Laroche F, Azoulay D, Trouvin AP, Coste J, Perrot S. Fibromyalgia in the workplace: risk factors for sick leave are related to professional context rather than fibromyalgia characteristics - a French national survey of 955 patients. BMC Rheumatol. 2019;3(44). doi: 10.1186/s41927-019-0089-0.

D'Onghia M, Ciaffi J, Ruscitti P, Cipriani P, Giacomelli R, Ablin JN, Ursini F. The economic burden of fibromyalgia: a systematic literature review. Semin Arthritis Rheum. 2022;56:152060. doi: 10.1016/j.semarthrit.2022.152060.

Gharibpoor F, Nasrollahzadeh E, Ghavidel‐Parsa B, Ghaffari ME, Bidari A. High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study. Int J Rheum Dis. 2021;24(5):671-680. doi:10.1111/1756-185X.14094.

Montesó-Curto P, Cubí-Guillen MT, Lladser Navarro AN, Puig Llobet M, Toussaint L. Family perceptions and experiences of living with patients with fibromyalgia syndrome. Disabil Rehabil. 2022;44(20):5855-62. doi: 10.1080/09638288.2021.1948620.

Lozano JE, Leal T, Peña-Altamar M, Olivera S, Núñez N. Depresión, ansiedad, apoyo interpersonal y dolor autopercibido en pacientes con síndrome de fibromialgia. Diversitas: Perspectivas en Psicología. 2020;16(2):399-411. doi: 10.15332/22563067.5007.

Brooks BD, Kaniuka AR, Rabon JK, Sirois FM, Hirsch JK. Social support and subjective health in fibromyalgia: self-compassion as a mediator. J Clin Psychol Med Settings. 2022;29:375-83. doi: 10.1007/s10880-021-09832-x.

Huang ER, Jones KD, Bennett RM, Hall GCN, Lyons KS. The role of spousal relationships in fibromyalgia patients’ quality of life. Psychol Health Med. 2018;23(8):987-995.

Sanabria-Mazo JP, Gers-Estrada M. Implications of chronic pain on the quality of life of women with fibromyalgia. Psicologia em Estudo. 2020;23. doi: 10.4025/psicolestud.v23.e38447.

Gower C, Trevitt J, Cherry BJ, Zettel-Watson L. Distress as a mediator for pain and activities of daily living in older adults with fibromyalgia. Front Med. 2022;9:1033936. doi:10.3389/fmed.2022.1033936.

Dueñas M, Salazar A, de Sola H, Failde I. Limitations in activities of daily living in people with chronic pain: Identification of groups using cluster analysis. Pain Pract. 2020;20(2):179-87. Available from: https://pubmed.ncbi.nlm.nih.gov/31556216/.

Kramer S, Deuschle L, Kohls N, Offenbächer M, Winkelmann A. The Importance of Daily Activity for Reducing Fibromyalgia Symptoms: A Retrospective "Real World" Data Comparison of two Multimodal Treatment Programs. Arch Rheumatol. 2020;35(4):575–583. doi: 10.46497/ArchRheumatol.2021.7739.

Segura-Jiménez V, Estévez-López F, Soriano-Maldonado A, Álvarez-Gallardo IC, Delgado-Fernández M, Ruiz JR, Aparicio VA. Gender differences in symptoms, health-related quality of life, sleep quality, mental health, cognitive performance, pain-cognition, and positive health in Spanish fibromyalgia individuals: The Al-Ándalus project. Pain Res Manag. 2016;2016:5135176. doi: 10.1155/2016/5135176.

Ataoğlu S, Ankaralı H, Ankaralı S, Ataoğlu BB, Ölmez SB. Quality of life in fibromyalgia, osteoarthritis and rheumatoid arthritis patients: Comparison of different scales. Egypt Rheumatol. 2018;40(3):203-8. doi: 10.1016/j.ejr.2017.09.007.

North J, Hong K-S, Rauck R. The effect of a novel form of extended-release gabapentin on pain and sleep in fibromyalgia subjects: an open-label pilot study. Pain Pract. 2016;16:720-9. doi: 10.1111/papr.12319.

Arnold L, Choy E, Clauw D, Oka H, Whalen E, Semel D, Pauer L, Knapp L. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin. 2018;34(8):1397-409. doi: 10.1080/03007995.2018.1450743.

Farag HM, Yunusa I, Goswami H, Sultan I, Doucette JA, Eguale T. Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: A systematic review and network meta-analysis. JAMA Netw Open. 2022;5(5). doi:10.1001/jamanetworkopen.2022.12939.

Dias Á, Eberle L, Alves T, da Silva T. Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Adv Rheumatol. 2020;60(35). doi: 10.1186/s42358-020-00137-5.

Gupta H, Girma B, Jenkins JS, Kaufman SE, Lee CA, Kaye AD. Milnacipran for the treatment of fibromyalgia. Health Psychol Res. 2021;9(1):25532. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567778/.

Lederman S, Arnold LM, Vaughn B, Kelley M, Sullivan GM. Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Care Res. 2023;75(11):2359-2368. doi: 10.1002/acr.25142.

Pereira A, Christianini C, Pereira AC, da Silva AG, Civile V, Moça VF. Tramadol for management of fibromyalgia pain and symptoms: Systematic review. Int J Clin Pract. 2020;74(3). doi: 10.1111/ijcp.13455.

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018;(2). doi:10.1002/14651858.CD010292.pub2.

Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020;2020:6541798. doi: 10.1155/2020/6541798.

Taylor SJ, Steer M, Ashe SC, Furness PJ, Haywood-Small S, Lawson K. Patients’ perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia. Scand J Pain. 2019;19(1):167-181. doi: 10.1515/sjpain-2018-0116.

Luciano J, Neblett R, Peñacoba C, Suso-Ribera C, McCracken L. The contribution of the psychologist in the assessment and treatment of fibromyalgia. Curr Treat Options Rheum. 2023;9:11-31. doi: 10.1007/s40674-023-00200-4.

Thieme K, Mathys M, Turk D. Evidenced-based guidelines on the treatment of fibromyalgia patients: are they consistent and if not, why not? Have effective psychological treatments been overlooked? J Pain. 2017;18(7):747-756. doi: 10.1016/j.jpain.2016.12.006.

Heller H, Borges A, Franco L, Aucelio J, Vargas M, Lorga R, Sales M, Nascimento N, Netto G, Passos B, Paes B, Mendes B, Lyra B, Santos C, Santos G, Oliveira M, Silva M, Jesus M, Storni P, Reis A. Role of cognitive behavioral therapy in fibromyalgia: A systematic review. Open J Rheumatol Autoimmun Dis. 2021;11(4):169-187. doi:10.4236/ojra.2021.114018.

Chan J, Lazaridou A, Paschali M, Loggia ML, Berry MP, Ellingsen DM, Isenburg K, Anzolín A, Grahl A, Wasan A, Napadow V, Edwards R. A randomized controlled neuroimaging trial of cognitive behavioral therapy for fibromyalgia pain. Arthritis Rheumatol. 2023;76(1):130-40. doi: 10.1002/art.42672.

Zabihiyeganeh M, Afshar SV, Kadijani AA, Jafari D, Bagherifard A, Janbozorgi M, Akbari A, Mirzaei A. The effect of cognitive behavioral therapy on the circulating proinflammatory cytokines of fibromyalgia patients: A pilot controlled clinical trial. Gen Hosp Psychiatry. 2019;57:23-8. doi:10.1016/j.genhosppsych.2019.01.003.

Kong KR, Lee EN. Effects of a Cognitive Behavior Therapy Program for Patients with Fibromyalgia Syndrome: A Randomized Controlled Trial. J Korean Acad Nurs. 2021;51(3):347-362. doi: 10.4040/jkan.21025.

Bernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of internet‐delivered psychological therapies for fibromyalgia syndrome: A systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2019;23(1):3-14. doi: 10.1002/ejp.1284.

Eastwood F, Godfrey E. The efficacy, acceptability and safety of acceptance and commitment therapy for fibromyalgia–a systematic review and meta-analysis. Br J Pain. 2023;20494637231221451. doi:10.1177/20494637231221451.

Akbarian M, Mohammadi Shirmahleh F, Borjali A, Hasanabadi H, Abolghasemi S. Effect of acceptance and commitment therapy on depression, chronic fatigue, and pain intensity in patients with fibromyalgia syndrome: A study with expectancy effect. Int Med Today. 2021;28(1):70-85. Available from: http://imtj.gmu.ac.ir/article-1-3684-en.html.

Aman M, Jason-Yong R, Kaye A, Urman R. Evidence-based non-pharmacological therapies for fibromyalgia. Curr Pain Headache Rep. 2018;22(33). doi: 10.1007/s11916-018-0688-2.

Van Gordon W, Shonin E, Dunn T, Garcia-Campayo J, Griffiths M. Meditation awareness training for the treatment of fibromyalgia syndrome: A randomized controlled trial. Br J Health Psychol. 2017;22(1):186-206. doi: 10.1111/bjhp.12224.

Pleman B, Park M, Han X, Price L, Bannuru R, Harvey W, Driban J, Wang C. Mindfulness is associated with psychological health and moderates the impact of fibromyalgia. Clin Rheumatol. 2019;38(6):1737-1745. doi: 10.1007/s10067-019-04436-1.

Park M, Zhang Y, Price L, Bannuru R, Wang C. Mindfulness is associated with sleep quality among patients with fibromyalgia. Int J Rheum Dis. 2020;23(3):294-301. doi: 10.1111/1756-185X.13756.

Andrés-Rodríguez L, Borràs X, Feliu-Soler A, Pérez-Aranda A, Rozadilla-Sacanell A, Montero-Marin J, Maes M, Luciano J. Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with mindfulness-based stress reduction (MBSR): A randomized, controlled clinical trial. Brain Behav Immun. 2019;80:109-19. doi: 10.1016/j.bbi.2019.02.030.

Galvez-Sánchez C, Montoro C. Psychoeducation for fibromyalgia syndrome: A systematic review of emotional, clinical and functional related-outcomes. Behav Sci. 2023;13(5):415. doi:10.3390/bs13050415.

Conversano C, Poli A, Ciacchini R, Hitchcott P, Bazzichi L, Gemignani A. A psychoeducational intervention is a treatment for fibromyalgia syndrome. Clin Exp Rheumatol. 2019;37(116). Available from: https://pubmed.ncbi.nlm.nih.gov/30747101/.

Romeo A, Tesio V, Ghiggia A, Di Tella M, Perutelli V, Castelli L. The efficacy of Brief Psychodynamic Psychotherapy for fibromyalgia: a pilot study. Psychother Psychosom. 2019;88(Suppl 1):110-110. Available from: https://hdl.handle.net/11368/3067225.

Farzadkia M, Farhangi A, Abolghasemi S. Comparing the effectiveness of mindfulness-based stress reduction and intensive short-term dynamic psychotherapy in reducing intolerance of uncertainty and depression in women with fibromyalgia. Womens Health Bull. 2023;10(1):44-51. doi:10.30476/whb.2023.97334.1206.

Aravena V, García FE, Téllez A, Arias PR. Hypnotic intervention in people with fibromyalgia: A randomized controlled trial. Am J Clin Hypn. 2020;63(1):49-61. doi: 10.1080/00029157.2020.1742088.

De Benedittis G. The challenge of fibromyalgia efficacy of hypnosis in alleviating the invisible pain: A narrative review. Int J Clin Exp Hypn. 2023;71(4):276-96. doi: 10.1080/00207144.2023.2247443.

Häuser W, De Benedittis G. Hypnosis and fibromyalgia syndrome. In: The Routledge International Handbook of Clinical Hypnosis. Routledge; 2024. p. 640-649.

Caballol-Angelats R, Gonçalves AQ, Aguilar Martín C, Sancho Sol MC, González Serra G, Casajuana M, Carrasco-Querol N, Fernández-Sáez J, Dalmau Llorca MR, Abellana R, Berenguera A, SensiTEbre group. Effectiveness, cost-utility, and benefits of a multicomponent therapy to improve the quality of life of patients with fibromyalgia in primary care: A mixed methods study protocol. Medicine. 2019;98(41). doi: 10.1097/MD.0000000000017289.

Arfuch VM, Gonçalves AQ, Caballol-Angelats R, Aguilar-Martin C, Carrasco-Querol N, Sancho-Sol M, González-Serra G, Fusté-Anguera I, Berenguera A. Patients' appraisals about a multicomponent intervention for fibromyalgia syndrome in primary care: A focus group study. Int J Qual Stud Health Well-being. 2021;16(1). doi: 10.1080/17482631.2021.2005760.

Zhang XC, Chen H, Xu WT, Song YY, Gu YH, Ni GX. Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials. J Pain Res. 2019;12:527-42. doi:10.2147/JPR.S186227.

Lee J, Park SH, Ju J, Cho J. Application of a real-time pain monitoring system in Korean fibromyalgia patients: A pilot study. Int J Rheum Dis. 2019;22:934-939. doi: 10.1111/1756-185X.13472.

Llàdser AN, Montesó-Curto P, López C, Rosselló L, Lear S, Toussaint L, et al. Multidisciplinary rehabilitation treatments for patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2022;58(1):76-84. doi: 10.23736/S1973-9087.21.06432-7.

Amable-Ambrós Z, Perojo V. Políticas públicas desde la visión sanológica. In: Acosta-Sariego J, editor. Bioética y Biopolítica. Publicaciones Acuario; 2023. p. 656-66.

Rodríguez A, Casas D, Contreras G, Ruano L. De la enfermología a la salutogénesis: conceptos teóricos en la búsqueda de la salud como derecho universal. Rev Med Univ Costa Rica. 2016;9(2):1-8. doi: 10.15517/rmu.v9i2.21988.

Sánchez-Piedrahita L, Amable-Ambrós Z, Núñez N. Calidad de vida de las personas con alteraciones mentales que asisten al “Hospital Día” con estrategia sanológica. Psiquiatria.com. 2021;25:1-17. Available from: http://psiqu.com/1-10718.

Reyes-Gaspar P, Charry-Méndez S. Efecto de un programa de ejercicio físico con enfoque sanológico en población universitaria. Retos. 2024;51:267-274. doi: 10.47197/retos.v51.99354.

Cabrera-Díaz E, Reyes-Gaspar P, Charry-Méndez S. Efectos de un programa de ejercicio físico con enfoque sanológico en universitarios. Med UPB. 2024;43(1):11-21. doi: 10.18566/medupb.v43n1.a03.

Sánchez-Piedrahita L, Ostos H, Barreiro F, Núñez N. Estrategia sanológica en madres cuidadoras de hijos con discapacidad genética (conferencia). In: Convención Internacional de Salud, Cuba Salud 2018; La Habana, Cuba. 2018 Jan. Available from: http://www.convencionsalud2018.sld.cu/index.php/connvencionsalud/2018/paper/viewFile/822/891.

Basain J, Valdés M. La salud física y la neuroplasticidad como elementos preventivos en el estado de bienestar humano. GADE: Rev Cient. 2023;3(2):282-96. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=8946770.

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.